| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 8e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |